Published in:
Open Access
01-12-2014 | Oral presentation
Early access to medicinal products: potential and limits
Author:
Pauline J Evers
Published in:
Orphanet Journal of Rare Diseases
|
Special Issue 1/2014
Login to get access
Excerpt
On average it takes 12 years and a billion euros to develop a new medicinal product from first discovery to availability for patients. Especially in the later stages of development, when promising phase 2 data are available it is difficult to accept for patients there is no general access. In order to make medicines available at an earlier stage and to optimise their development, new ways of taking medicines through the assessment procedures for registration and reimbursement are highly needed. …